FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1520952908> ?p ?o ?g. }

• W1520952908 endingPage "1472" @default.
• W1520952908 startingPage "1467" @default.
• W1520952908 abstract "Abstract Background and Aim: Interleukin‐28B ( IL28B ) single nucleotide polymorphism (SNP) influences viral response (VR) to interferon (IFN) therapy in patients with hepatitis C. We studied the relationship between VR and the IL28B polymorphism (rs8099917) in patients on long‐term pegylated IFN plus ribavirin (PEGIFN/RBV) therapy for recurrent hepatitis C after living‐donor liver transplantation (LDLT). Methods: Thirty‐five patients with recurrent hepatitis C after LDLT were treated with PEGIFN/RBV. We evaluated the effect of IL28B SNP on the outcome in 20 patients infected with hepatitis C virus genotype 1 who completed IFN therapy. Results: The sustained VR (SVR) rate was 54% (19/35) for all patients; 46% (13/28) for genotype 1. The SVR rate of donors' TT group (major genotype) was higher than that of donors' TG + GG group (minor genotype) (73% vs 20%), while that of recipients' TT group was similar to that of recipients' TG + GG group (64% vs 50%). With regard to the combined effect of donors' and recipients' IL28B SNP, the SVR rates of TT : TT (donors' : recipients'), TT : TG + GG, TG + GG : any group were 81%, 50%, and 20%, respectively. The VR rate of TT : TT, TT : TG + GG and TG + GG : any group at 12 weeks were 28%, 0%, and 0%; those at 48 weeks were 70%, 50%, 20%, and those at the end of treatment were 100%, 50%, 20%, respectively. The multivariate analysis identified IL28B of donors : recipients (TT : TT) as the only independent determinant of SVR (odds ratio 15.0, P = 0.035). Conclusion: Measurement of donors' and recipients' IL28B SNP can predict the response to PEGIFN/RBV therapy, and the donors' IL28B SNP might be a more significant predictor than that of the recipients." @default.
• W1520952908 created "2016-06-24" @default.
• W1520952908 creator A5008287349 @default.
• W1520952908 creator A5013608005 @default.
• W1520952908 creator A5016882648 @default.
• W1520952908 creator A5018431544 @default.
• W1520952908 creator A5019195799 @default.
• W1520952908 creator A5019763674 @default.
• W1520952908 creator A5022484621 @default.
• W1520952908 creator A5023958825 @default.
• W1520952908 creator A5027196488 @default.
• W1520952908 creator A5027695992 @default.
• W1520952908 creator A5031469873 @default.
• W1520952908 creator A5034077858 @default.
• W1520952908 creator A5044269436 @default.
• W1520952908 creator A5047908112 @default.
• W1520952908 creator A5063059796 @default.
• W1520952908 creator A5070035943 @default.
• W1520952908 date "2012-08-21" @default.
• W1520952908 modified "2023-10-15" @default.
• W1520952908 title "Interleukin‐28B single nucleotide polymorphism of donors and recipients can predict viral response to pegylated interferon/ribavirin therapy in patients with recurrent hepatitis C after living donor liver transplantation" @default.
• W1520952908 cites W1526698346 @default.
• W1520952908 cites W1676445325 @default.
• W1520952908 cites W1966112709 @default.
• W1520952908 cites W1968878988 @default.
• W1520952908 cites W1979700502 @default.
• W1520952908 cites W1982188458 @default.
• W1520952908 cites W1985891278 @default.
• W1520952908 cites W1992210588 @default.
• W1520952908 cites W1996826897 @default.
• W1520952908 cites W1999996561 @default.
• W1520952908 cites W2015339598 @default.
• W1520952908 cites W2016205218 @default.
• W1520952908 cites W2016264175 @default.
• W1520952908 cites W2017013905 @default.
• W1520952908 cites W2026614040 @default.
• W1520952908 cites W2031976676 @default.
• W1520952908 cites W2032702560 @default.
• W1520952908 cites W2035504234 @default.
• W1520952908 cites W2036646541 @default.
• W1520952908 cites W2041421438 @default.
• W1520952908 cites W2042149897 @default.
• W1520952908 cites W2047208492 @default.
• W1520952908 cites W2058538904 @default.
• W1520952908 cites W2061749406 @default.
• W1520952908 cites W2063285149 @default.
• W1520952908 cites W2065084710 @default.
• W1520952908 cites W2067016841 @default.
• W1520952908 cites W2079519870 @default.
• W1520952908 cites W2084112737 @default.
• W1520952908 cites W2086414517 @default.
• W1520952908 cites W2086641001 @default.
• W1520952908 cites W2092659785 @default.
• W1520952908 cites W2102079012 @default.
• W1520952908 cites W2107639148 @default.
• W1520952908 cites W2128390124 @default.
• W1520952908 cites W2128623775 @default.
• W1520952908 cites W2140323943 @default.
• W1520952908 cites W2150209147 @default.
• W1520952908 cites W52288074 @default.
• W1520952908 doi "https://doi.org/10.1111/j.1440-1746.2012.07129.x" @default.
• W1520952908 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22432893" @default.
• W1520952908 hasPublicationYear "2012" @default.
• W1520952908 type Work @default.
• W1520952908 sameAs 1520952908 @default.
• W1520952908 citedByCount "11" @default.
• W1520952908 countsByYear W15209529082012 @default.
• W1520952908 countsByYear W15209529082013 @default.
• W1520952908 countsByYear W15209529082014 @default.
• W1520952908 crossrefType "journal-article" @default.
• W1520952908 hasAuthorship W1520952908A5008287349 @default.
• W1520952908 hasAuthorship W1520952908A5013608005 @default.
• W1520952908 hasAuthorship W1520952908A5016882648 @default.
• W1520952908 hasAuthorship W1520952908A5018431544 @default.
• W1520952908 hasAuthorship W1520952908A5019195799 @default.
• W1520952908 hasAuthorship W1520952908A5019763674 @default.
• W1520952908 hasAuthorship W1520952908A5022484621 @default.
• W1520952908 hasAuthorship W1520952908A5023958825 @default.
• W1520952908 hasAuthorship W1520952908A5027196488 @default.
• W1520952908 hasAuthorship W1520952908A5027695992 @default.
• W1520952908 hasAuthorship W1520952908A5031469873 @default.
• W1520952908 hasAuthorship W1520952908A5034077858 @default.
• W1520952908 hasAuthorship W1520952908A5044269436 @default.
• W1520952908 hasAuthorship W1520952908A5047908112 @default.
• W1520952908 hasAuthorship W1520952908A5063059796 @default.
• W1520952908 hasAuthorship W1520952908A5070035943 @default.
• W1520952908 hasConcept C104317684 @default.
• W1520952908 hasConcept C126322002 @default.
• W1520952908 hasConcept C135763542 @default.
• W1520952908 hasConcept C153209595 @default.
• W1520952908 hasConcept C156957248 @default.
• W1520952908 hasConcept C203014093 @default.
• W1520952908 hasConcept C2522874641 @default.
• W1520952908 hasConcept C2776408679 @default.
• W1520952908 hasConcept C2776455275 @default.
• W1520952908 hasConcept C2776461080 @default.
• W1520952908 hasConcept C2779609443 @default.
• W1520952908 hasConcept C2780040827 @default.

• next